Abstract:Leptospirosis is the most widespread zoonosis and a life-threatening disease in humans and animals. Licensed killed whole-cell vaccines are available for animals; however, they do not offer heterologous protection, do not induce long-term protection, or prevent renal colonization. In this study, we characterized an immunogenic Leptospira methyl-accepting chemotaxis protein (MCP) identified through a reverse vaccinology approach, predicted its structure, and tested the protective efficacy of a recombinant MCP fragment in the C3H/HeJ mice model. The predicted structure of the full-length MCP revealed an architecture typical for topology class I MCPs. A single dose of MCP vaccine elicited a significant IgG antibody response in immunized mice compared to controls ( P < 0.0001), especially the IgG1 and IgG2a subclasses. The vaccination with MCP, despite eliciting a robust immune response, did not protect mice from disease and renal colonization. However, survival curves significantly differed between groups, and the MCP-vaccinated group developed clinical signs faster than the control group. There were differences in gross and histopathological changes between the MCP-vaccinated and control groups. The factors leading to enhanced disease process in vaccinated animals need further investigation. We speculate that anti-MCP antibodies may block the MCP signaling cascade and may limit chemotaxis, preventing Leptospira from reaching its destination, but facilitating its maintenance and replication in the blood stream. Such a phenomenon may exist in endemic areas where humans are highly exposed to Leptospira antigens, and the presence of antibodies might lead to disease enhancement. The role of this protein in Leptospira pathogenesis should be further evaluated to comprehend the lack of protection and potential exacerbation of the disease process. The absence of immune correlates of protection from Leptospira infection is still a major limitation of this field and efforts to gather this knowledge are needed. Leptospirosis is one of the underrecognized and neglected diseases of humans and animals. The presence of numerous Leptospira species/serovars infecting a broad range of animal reservoirs, and the resulting environmental contamination, makes control and prevention a cumbersome task. The bacterin-based vaccines available for animals do offer a limited protection against disease or renal colonization. A broader cross-protective vaccine is essentially needed to prevent Leptospira infections in humans and animals. Here we rationally selected a protein target based on its capacity to be recognized by antibodies of naturally infected animals and designed a recombinant vaccine. Our MCP vaccine was not effective in protecting mice from acute and chronic disease and likely led to exacerbation of clinical signs in these animals. The development of an effective vaccine would contribute to controlling Leptospira infection in humans and animals and is important, especially in low-income regions where leptospirosis is more prevalent and interventions to control the disease are not currently available.

Inflammatory Signatures of Pathogenic and Non-Pathogenic Leptospira Infection in Susceptible C3H-HeJ Mice

Leptospiral Lipopolysaccharide-Induced Expression of Inflammatory Cytokines and Mononuclear-Mac-rophage Infiltration in Viscera of Mice with Leptospira Interrogans Infection

Leptospiral Hemolysins Induce Proinflammatory Cytokines Through Toll-like Receptor 2-and 4-Mediated JNK and NF-κB Signaling Pathways.

Differences Between Infiltration of Mononuclear-Macrophages and Neutrophils During Leptospira Inter-Rogans Infection and Underlying Mechanisms

Exposure to live saprophytic Leptospira before challenge with a pathogenic serovar prevents severe leptospirosis and promotes kidney homeostasis

M16-Type Metallopeptidases Are Involved in Virulence for Invasiveness and Diffusion of <i>Leptospira interrogans</i> and Transmission of Leptospirosis

Replication Or Death: Distinct Fates Of Pathogenic Leptospira Strain Lai Within Macrophages Of Human Or Mouse Origin

Leptospirosis is an invasive infectious and systemic inflammatory disease

Exoproteome from Leptospira interrogans and Host Cells during Infection: Leptospiral Virulence Factors and Cellular Proteins Involved in Stress and Inflammation

Transcriptional Responses of Leptospira Interrogans to Host Innate Immunity: Significant Changes in Metabolism, Oxygen Tolerance, and Outer Membrane

Exposure to live saprophytic before challenge with a pathogenic serovar prevents severe leptospirosis and promotes kidney homeostasis

Infection with Opportunistic Bacteria Triggers Severe Pulmonary Inflammation in Lupus-Prone Mice

M16-Type Metallopeptidases Are Important Virulence Factors for Invasiveness and Diffusion of <i>leptospira Interrogans</i> and Transmission of Leptospirosis

The Role Of Reactive Oxygen Intermediates In The Intracellular Fate Of Leptospira Interrogans In The Macrophages Of Different Hosts

Hemolysin Sph2 from Leptospira interrogans amplified inflammatory response in murine macrophages J774A.1 through HMGB1

Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells

Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge

A New Model of Self-Resolving Leptospirosis in Mice Infected with a Strain of Leptospira Interrogans Serovar Autumnalis Harboring LPS Signaling Only Through TLR4

A Mouse Model of Sublethal Leptospirosis: Protocols for Infection with Leptospira Through Natural Transmission Routes, for Monitoring Clinical and Molecular Scores of Disease, and for Evaluation of the Host Immune Response

Signaling via ITGB1/FAK and microfilament rearrangement mediates the internalization of Leptospira interrogans in mouse J774A.1 macrophages

Identification and Characterization of C-Di-gmp Metabolic Enzymes of Leptospira Interrogans and C-Di-gmp Fluctuations after Thermal Shift and Infection